1. Home
  2. LOAN vs NEPH Comparison

LOAN vs NEPH Comparison

Compare LOAN & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • NEPH
  • Stock Information
  • Founded
  • LOAN 1989
  • NEPH 1997
  • Country
  • LOAN United States
  • NEPH United States
  • Employees
  • LOAN N/A
  • NEPH N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • NEPH Medical/Dental Instruments
  • Sector
  • LOAN Real Estate
  • NEPH Health Care
  • Exchange
  • LOAN Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • LOAN 61.0M
  • NEPH 57.2M
  • IPO Year
  • LOAN 1999
  • NEPH 2004
  • Fundamental
  • Price
  • LOAN $4.93
  • NEPH $5.31
  • Analyst Decision
  • LOAN
  • NEPH Strong Buy
  • Analyst Count
  • LOAN 0
  • NEPH 2
  • Target Price
  • LOAN N/A
  • NEPH $5.50
  • AVG Volume (30 Days)
  • LOAN 44.2K
  • NEPH 85.2K
  • Earning Date
  • LOAN 10-24-2025
  • NEPH 11-05-2025
  • Dividend Yield
  • LOAN 9.41%
  • NEPH N/A
  • EPS Growth
  • LOAN N/A
  • NEPH N/A
  • EPS
  • LOAN 0.46
  • NEPH 0.12
  • Revenue
  • LOAN $7,138,128.00
  • NEPH $16,684,000.00
  • Revenue This Year
  • LOAN N/A
  • NEPH $24.38
  • Revenue Next Year
  • LOAN $4.47
  • NEPH $10.16
  • P/E Ratio
  • LOAN $10.56
  • NEPH $47.07
  • Revenue Growth
  • LOAN N/A
  • NEPH 21.16
  • 52 Week Low
  • LOAN $4.74
  • NEPH $1.39
  • 52 Week High
  • LOAN $6.05
  • NEPH $5.98
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 30.57
  • NEPH 53.84
  • Support Level
  • LOAN $4.83
  • NEPH $4.86
  • Resistance Level
  • LOAN $5.19
  • NEPH $5.97
  • Average True Range (ATR)
  • LOAN 0.12
  • NEPH 0.47
  • MACD
  • LOAN -0.04
  • NEPH -0.01
  • Stochastic Oscillator
  • LOAN 18.88
  • NEPH 54.48

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: